Financial figures

          Overview of DSM's latest financial key figures

          Overview as at publication Q1 2020 results

          Presented below are DSM's net sales from continuing operations, adjusted net earnings per ordinary share, balance sheet, income statement and finally, cash flow statement, as at Q1 2020.

          Net sales (continuing operations) in € million

          Year Q1 Q2 Q3 Q4 Total
          2020 2,293 ? ? ? ?
          2019 2,292 2,276 2,290 2,152 9,010
          2018 2,435 2,359 2,265 2,208 9,267
          2017 2,159 2,161 2,136 2,176 8,632
          2016 1,913 1,994 1,998 2,015 7,920
          2015 1,886 1,754 2,102 1,926 7,722
          2014 2,298 2,288 2,323 2,175 9,181
          2013 2,376 2,468 2,397 2,377 9,618
          2012 2,290 2,268 2,304 2,269 9,131
          2011 2,234 2,265 2,322 2,227 9,048
          2010 1,933 2,120 2,041 2,082 8,176
          2009 1,578 1,664 1,725 1,758 6,725
          2008 2,303 2,406 2,336 2,034 9,079

          Adjusted net earnings per ordinary share (continuing operations)

          Year Q1 Q2 Q3 Q4 Total
          2020 1.24 ? ? ? ?
          2019 1.12 1.20 1.36 0.96 4.64
          2018 1.91 1.73 1.18 1.02 5.84
          2017 0.92 0.98 0.91 1.11 3.92
          2016 0.60 0.76 0.81 0.73 2.90
          2015 0.39 0.63 0.59 0.53 2.14
          2014 0.57 0.64 0.69 0.52 2.42
          2013 0.70 0.79 0.76 0.58 2.84
          2012 0.87 0.67 0.61 0.43 2.58
          2011 0.91 0.97 0.94 0.71 3.53
          2010 0.70 0.92 0.76 0.63 2.89
          2009 0.05 0.22 0.53 0.56 1.44
          2008 0.81 1.00 0.97 0.25 3.04

          Balance sheet

          Assets?in € million Q1 2020 Year-end?2019
          Intangible Assets 3,487 3,515
          Property, Plant & Equipment 4,012 4,040
          Deferred Tax Assets 225 217
          Share in Associates & Joint Ventures 153 155
          Financial derivatives 42 27
          Other Financial Assets 256 265
          Non-Current Assets 8,175 8,219
          Inventories 2,137 2,019
          Trade Receivables 1,790 1,592
          Income tax receivables 54 61
          Other Current Receivables 46 45
          Financial Derivatives 21 19
          Current Investments 195 688
          Cash & Cash Equivalents 1,396 800
          Current Assets 5,639 5,224
          Total Assets 13,814 13,443
          Shareholders' Equity 7,560 7,731
          Non-controlling interest 103 104
          Equity 7,663 7,835
          Deferred Tax Liabilities 283 296
          Employee Benefits Liabilities 413 413
          Provisions 120 120
          Borrowings 2,470 2,464
          Financial derivatives 13 7
          Other Non-current Liabilities 154 145
          Non-current liabilities 3,453 3,445
          Employee Benefits 44 43
          Provisions 83 48
          Borrowings 450 189
          Financial Derivatives 45 18
          Trade Payables 1,554 1,345
          Income tax payable 43 42
          Other Current Liabilities 479 478
          Current Liabilities 2,698 2,163
          Total Equity and Liabilities 13,814 13,443

          Income statement

          Condensed consolidated statement of income Q1 2020

          In €?million Q1 2020 Q1 2019
          Sales 2,293 2,292
          EBITDA 358 416
          Operating profit (EBIT) 207 271
          Financial income and expense -13 -29
          Profit before income tax expense 194 242
          Income tax expense -30 -44
          Share of the profit of associates /joint control entities 4 -2
          Net profit 168 196
          Of which: ? ?
          Profit attributable to non-controlling interests -1 -1
          Net profit attributable to equity holders of DSM 167 195
          Dividend on cumulative preference shares -2 -2
          Net profit available to holders of ordinary shares 165 193
          Depreciation and amortization 151 145

          Reconciliation to Alternative Performance Measures Q1 2020

          In €?million Q1 2020 Q1 2019
          EBITDA 358 416
          Acquisitions/divestments? 9 3
          Restructuring? 56 5
          Other 0 0
          Sub-total APM adjustments to EBITDA 65 8
          Adjusted EBITDA 423 424
          Operating profit (EBIT) 207 271
          APM adjustments to EBITDA 65 8
          Impairments of PPE and Intangible assets 0 0
          Sub-total APM adjustments to operating profit (EBIT) 65 8
          Adjusted operating profit (EBIT) 272 279
          Net profit 168 196
          APM adjustments to operating profit (EBIT) 65 8
          APM adjustments to financial income and expense 0 0
          Income tax related to APM adjustments -16 -1
          APM adjustments to share of the profit of associates /joint control entities -1 -3
          Sub-total APM adjustments to net profit? 48 4
          Adjusted net profit 216 200
          ? ? ?
          Net profit available to holders of ordinary shares 165 193
          APM adjustments to net profit 48 4
          Adjusted net profit available to holders of?ordinary shares 213 197

          Cash flow statement

          Assets in € million Q1 2020 Q1 2019
          Cash, Cash Equivalents and Current Investments (at beginning of period) 1,488 2,558
          Current Investments (at beginning of period) 688 1,277
          Cash & Cash Equivalents (at beginning of period) 800 1,281
          Operating Activities ? ?
          EBITDA 358 416
          Change in Working? Capital -100 -165
          Income Tax -30 -24
          Other 59 -26
          Cash provided by Operating Activities (Operating cash flow) 287 201
          Investing Activities ? ?
          Capital Expenditures -152 -150
          Payments regarding drawing rights -4 -2
          Acquisitions -4 -157
          Disposal of Subsidiaries, Businesses & Associates 1 2
          Disposal of Other Non-current Assets ? 3
          Change in Fixed-term Deposits 493 -153
          Interest Received 1 1
          Dividend and capital (re)payments? -6 -17
          Other -3 -1
          Cash used in Investing Activities 326 -474
          Interest Paid? -4 -5
          Repurchase of shares -283 0
          Proceeds from re-issued treasury shares 16 55
          Change in Commercial Paper 180 ?
          Payment of lease liabilities -14 -12
          Other Cash from/ used in Financing Activities 93 -2
          Cash from / used in Financing Activities -12 36
          Exchange Differences -5 -1
          Cash and Cash Equivalents (end of period) 1,396 1,043
          Current Investment (end of period)? 195 1,430
          Cash and Cash Equivalents & Current Investments (end of period) 1,591 2,473

          Read more

          • Share center

            DSM's ordinary shares, share performance, share listings, share structure, cumulative preference shares and shareholder base.

          This site uses cookies to store information on your computer.

          Learn more
          草莓app